Human non-pancreatic (group II) secreted phospholipase A2 expressed from a synthetic gene in Escherichia coli: characterisation of N-terminal mutants.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Biochimica et Biophysica Acta

• Publication date

  1996-09-27

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/0005-2760(96)00083-5PMID 8856038
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular Cloning: A Laboratory Manual

  2001cited by this paper
• The potent anti-Staphylococcus aureus activity of a sterile rabbit inflammatory fluid is due to a 14-kD phospholipase A2.

  1996cited by this paper
• Enhanced hydrolysis of phosphatidylcholine by human group II non-pancreatic secreted phospholipase A2 as a result of interfacial activation by specific anions. Potential role of cholesterol sulphate.

  1995cited by this paper
• Preparation and characterization of human rheumatoid arthritic synovial fluid phospholipase A2 produced by recombinant baculovirus-infected insect cells.

  1994cited by this paper
• Cloning and expression of a membrane receptor for secretory phospholipases A2.

  1994cited by this paper
• The region around residue 115 of human bactericidal/permeability-increasing protein is not involved in lipopolysaccharide binding or bactericidal activity. Chemical synthesis and expression of a gene coding for the active domain and characterization of recombinant proteins.

  1994cited by this paper
• Some properties of a human group II phospholipase A2 expressed from a synthetic gene in E. coli.

  1994cited by this paper
• Comparison of the properties of human group II phospholipase A2 with other secretory phospholipases.

  1994cited by this paper
• Inhibition of human secretory class II phospholipase A2 by heparin.

  1994cited by this paper
• Molecular cloning of pancreatic group I phospholipase A2 receptor.

  1994cited by this paper
• The electrostatic basis for the interfacial binding of secretory phospholipases A2.

  1994cited by this paper
• Diversity of group types, regulation, and function of phospholipase A2.

  1994cited by this paper
• Functional significance of the conformational dynamics of the N-terminal segment of secreted phospholipase A2 at the interface.

  1994cited by this paper
• Structural determinants of the action against Escherichia coli of a human inflammatory fluid phospholipase A2 in concert with polymorphonuclear leukocytes.

  1994cited by this paper
• Pancreatic-type phospholipase A2 induces group II phospholipase A2 expression and prostaglandin biosynthesis in rat mesangial cells.

  1994cited by this paper
• Recombinant human synovial fluid phospholipase A2 and N-terminal variant: kinetic parameters and response to inhibitors.

  1993cited by this paper
• Extracellular phospholipase A2 expression and inflammation: the relationship with associated disease states.

  1993cited by this paper
• Possible role of mammalian secretory group II phospholipase A2 in T-lymphocyte activation: implication in propagation of inflammatory reaction.

  1993cited by this paper
• Rat liver mitochondrial phospholipase A2 is an endotoxin-stimulated membrane-associated enzyme of Kupffer cells which is released during liver perfusion.

  1993cited by this paper
• Spectroscopic properties of the states of pig pancreatic phospholipase A2 at interfaces and their possible molecular origin.

  1993cited by this paper
• Human nonpancreatic secreted phospholipase A2: interfacial parameters, substrate specificities, and competitive inhibitors.

  1993cited by this paper
• Mammalian non-pancreatic phospholipases A2.

  1993cited by this paper
• Stereospecificity of the interaction of porcine pancreatic phospholipase A2 with micellar and monomeric inhibitors. A time-resolved fluorescence study of the tryptophan residue.

  1993cited by this paper
• Participation in cellular prostaglandin synthesis of type-II phospholipase A2 secreted and anchored on cell-surface heparan sulfate proteoglycan.

  1993cited by this paper
• Conformational changes in phospholipase A2 upon binding to micellar interfaces in the absence and presence of competitive inhibitors. A 1H and 15N NMR study.

  1992cited by this paper
• Renaturation of cobra venom phospholipase A2 expressed from a synthetic gene in Escherichia coli.

  1992cited by this paper
• A study of the 14 kDa phospholipase A2 from rat liver using a continuous fluorescent displacement assay for the enzyme.

  1992cited by this paper
• Purification and characterization of a mutant human platelet phospholipase A2 expressed in Escherichia coli. Cleavage of a fusion protein with cyanogen bromide.

  1992cited by this paper
• Purification, analysis, and enzymatic activity of recombinant human synovial fluid phospholipase A2 and N-terminal variants.

  1992cited by this paper
• A novel method for the purification of porcine phospholipase A2 expressed in E. coli.

  1991cited by this paper
• Comparison of the catalytic properties of phospholipase A2 from pancreas and venom using a continuous fluorescence displacement assay.

  1991cited by this paper
• Induction of phospholipase A2 gene expression in human hepatoma cells by mediators of the acute phase response.

  1991cited by this paper
• Synthesis of a gene for rat liver fatty-acid-binding protein and its expression in Escherichia coli.

  1991cited by this paper
• Eicosanoid generation from antigen‐primed mast cells by extracellular mammalian 14‐kDa group II phospholipase A2

  1991cited by this paper
• Augmentation of prostaglandin E2 production by mammalian phospholipase A2 added exogenously.

  1991cited by this paper
• A novel arachidonic acid-selective cytosolic PLA2 contains a Ca(2+)-dependent translocation domain with homology to PKC and GAP.

  1991cited by this paper
• Molecular cloning and expression of human Ca(2+)-sensitive cytosolic phospholipase A2.

  1991cited by this paper
• Purification of a cellular (granulocyte) and an extracellular (serum) phospholipase A2 that participate in the destruction of Escherichia coli in a rabbit inflammatory exudate.

  1990cited by this paper
• A continuous fluorescence displacement assay for the measurement of phospholipase A2 and other lipases that release long-chain fatty acids.

  1990cited by this paper
• Purification of rabbit platelet secretory phospholipase A2 and its characteristics.

  1989cited by this paper
• Structure and properties of a human non-pancreatic phospholipase A2.

  1989cited by this paper
• The primary structure of rat platelet phospholipase A2.

  1988cited by this paper
• Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes.

  1986cited by this paper
• Structural and functional properties of a phospholipase A2 purified from an inflammatory exudate.

  1986cited by this paper
• Rapid and efficient site-specific mutagenesis without phenotypic selection.

  1985cited by this paper
• Improved oligonucleotide site-directed mutagenesis using M13 vectors.

  1985cited by this paper
• Regulation of ribosomal RNA promoters with a synthetic lac operator.

  1984cited by this paper
• New M13 vectors for cloning.

  1983cited by this paper
• Role of the N-terminus in the interaction of pancreatic phospholipase A2 with aggregated substrates. Properties and crystal structure of transaminated phospholipase A2.

  1983cited by this paper
• [2] New M13 vectors for cloning

  1983cited by this paper
• Preferential codon usage in prokaryotic genes: the optimal codon-anticodon interaction energy and the selective codon usage in efficiently expressed genes.

  1982cited by this paper
• Regeneration of full enzymatic activity by reoxidation of reduced pancreatic phospholipase A2.

  1980cited by this paper
• Specific transformations at the N-terminal region of phospholipase A2.

  1975cited by this paper
• Polypeptide Chain Initiation: Nucleotide Sequences of the Three Ribosomal Binding Sites in Bacteriophage R17 RNA

  1969cited by this paper
• Polypeptide chain initiation: nucleotide sequences of the three ribosomal binding sites in bacteriophage R17 RNA.

  1969cited by this paper
• The L-arabinose permease system in Escherichia coli B/r.

  1966cited by this paper

• Secretory Phospholipases A2 in Plants

  2019cites this paper
• Roles of secreted phospholipase A2 group IIA in inflammation and host defense.

  2019cites this paper
• Kinetic characterization, optimum conditions for catalysis and substrate preference of secretory phospholipase A2 from Glycine max in model membrane systems.

  2015cites this paper
• Renaturation and one step purification of the chicken GIIA secreted phospholipase A2 from inclusion bodies.

  2014cites this paper
• Isolation and expression of a hypotensive and anti-platelet acidic phospholipase A2 from Bothrops moojeni snake venom.

  2013cites this paper
• Renaturation and one step purification of the chicken GIIA secreted phospholipase A2 from inclusion bodies.

  2013cites this paper
• Cloning and functional expression of secreted phospholipases A(2) from Bothrops diporus (Yarará Chica).

  2012cites this paper
• Active site mutants of human secreted Group IIA Phospholipase A2 lacking hydrolytic activity retain their bactericidal effect.

  2012cites this paper
• The Inactivation Mechanism of Human Group IIA Phospholipase A2 by Scalaradial

  2012cites this paper
• Kinetic properties of pancreatic and intestinal sPLA2 from chicken and mammals using the monomolecular film technique.

  2011cites this paper
• Structure-based design, synthesis and preliminary anti-inflammatory activity of bolinaquinone analogues.

  2011cites this paper
• The Binding Mode of Cladocoran A to the Human Group IIA Phospholipase A2

  2011cites this paper
• Changes in PLA(2) activity after interacting with anti-inflammatory drugs and model membranes: evidence for the involvement of tryptophan residues.

  2011cites this paper
• Crystal Structure of a Class XIB Phospholipase A2 (PLA2)

  2009cites this paper
• Mapping of suramin binding sites on the group IIA human secreted phospholipase A2.

  2009cites this paper
• Suramin inhibits macrophage activation by human group IIA phospholipase A2, but does not affect bactericidal activity of the enzyme

  2009cites this paper
• The molecular mechanism of human group IIA phospholipase A2 inactivation by bolinaquinone

  2009influential citation
• La phospholipase A2 sécrétée de groupe X : maturation protéolytique et rôles fonctionnels

  2009cites this paper
• Enhanced protein expression in mammalian cells using engineered SUMO fusions: Secreted phospholipase A2

  2008cites this paper
• Chemically induced dimerization of human nonpancreatic secretory phospholipase A2 by bis-indole derivatives.

  2008cites this paper
• A Catalytically Independent Physiological Function for Human Acute Phase Protein Group IIA Phospholipase A2

  2008cites this paper
• Recombinant production and properties of binding of the full set of mouse secreted phospholipases A2 to the mouse M-type receptor.

  2007cites this paper
• Production of synthetically created phospholipase A2 variants with industrial impact

  2007cites this paper
• Structure-activity relationship of 2-oxoamide inhibition of group IVA cytosolic phospholipase A2 and group V secreted phospholipase A2.

  2007cites this paper
• A continuous fluorescence assay for phospholipase A2 with nontagged lipid.

  2006cites this paper
• Structural and functional effects of tryptophans inserted into the membrane-binding and substrate-binding sites of human group IIA phospholipase A2.

  2006cites this paper
• Indole-5-phenylcarbamate derivatives as human non-pancreatic secretory phospholipase A2 inhibitor.

  2005cites this paper
• Evidence for the Regulatory Role of the N-terminal Helix of Secretory Phospholipase A2 from Studies on Native and Chimeric Proteins*

  2005cites this paper
• Cloning and expression of an acidic platelet aggregation inhibitor phospholipase A2 cDNA from Bothrops jararacussu venom gland.

  2004cites this paper
• Effect of tryptophan insertions on the properties of the human group IIA phospholipase A2: mutagenesis produces an enzyme with characteristics similar to those of the human group V phospholipase A2.

  2003cites this paper
• The Antibacterial Properties of Secreted Phospholipases A2

  2002cites this paper
• Bactericidal Properties of Human and Murine Groups I, II, V, X, and XII Secreted Phospholipases A2 *

  2002cites this paper
• The crystal structure of the H48Q active site mutant of human group IIA secreted phospholipase A2 at 1.5 A resolution provides an insight into the catalytic mechanism.

  2002cites this paper
• mRNA secondary structure can greatly affect production of recombinant phospholipase A(2) toxins in bacteria.

  2002cites this paper
• Interfacial enzymology: the secreted phospholipase A(2)-paradigm.

  2001cites this paper
• Expression, refolding, and activity of a recombinant nonhemorrhagic snake venom metalloprotease.

  2000cites this paper
• Bacterial cell membrane hydrolysis by secreted phospholipases A(2): a major physiological role of human group IIa sPLA(2) involving both bacterial cell wall penetration and interfacial catalysis.

  2000cites this paper
• Exogenously Added Human Group X Secreted Phospholipase A2 but Not the Group IB, IIA, and V Enzymes Efficiently Release Arachidonic Acid from Adherent Mammalian Cells*

  2000cites this paper
• Interfacial binding of secreted phospholipases A(2): more than electrostatics and a major role for tryptophan.

  1999cites this paper
• Roles of Trp31 in High Membrane Binding and Proinflammatory Activity of Human Group V Phospholipase A2 *

  1999cites this paper
• Phospholipase D and phosphatidic acid enhance the hydrolysis of phospholipids in vesicles and in cell membranes by human secreted phospholipase A2.

  1998cites this paper
• Bacterial expression and characterization of human secretory class V phospholipase A2.

  1998cites this paper
• Inhibition of secreted phospholipases A2 by annexin V. Competition for anionic phospholipid interfaces allows an assessment of the relative interfacial affinities of secreted phospholipases A2.

  1998cites this paper
• Tryptophan-containing mutant of human (group IIa) secreted phospholipase A2 has a dramatically increased ability to hydrolyze phosphatidylcholine vesicles and cell membranes.

  1998cites this paper
• Cardiolipin hydrolysis by human phospholipases A2. The multiple enzymatic activities of human cytosolic phospholipase A2.

  1998cites this paper
• Anionic phospholipids and the regulation of cell functions.

  1998cites this paper
• Purification and properties of an active site mutant, H48Q, of human non-pancreatic secreted phospholipase A2.

  1998cites this paper
• Action of human group IIa secreted phospholipase A2 on cell membranes. Vesicle but not heparinoid binding determines rate of fatty acid release by exogenously added enzyme.

  1998cites this paper
• The hydrolysis of biological membranes by secreted phospholipases A.

  1997cites this paper
• Combined effects of sphingomyelin and cholesterol on the hydrolysis of emulsion particle triolein by lipoprotein lipase.

  1997cites this paper
• Compartmentalisation and characteristics of a Ca2+-dependent phospholipase A2 in human colon mucosa.

  1997cites this paper
• The hydrolysis of phosphatidyl-alcohols by phospholipases A2: effect of head group size and polarity.

  1997cites this paper
• Gossypol modification of Ala-1 of secreted phospholipase A2: a probe for the kinetic effects of sulfate glycoconjugates.

  1997cites this paper